Severe Candida infections in critically ill patients with COVID-19
The frequency of co-infections with bacterial or fungal pathogens has constantly increased among critically ill patients with coronavirus disease 2019 (COVID-19) during the pandemic. Candidemia was the most frequently reported invasive fungal co-infection. The onset of candidemia in COVID-19 patient...
Main Authors: | Despoina Koulenti, Marios Karvouniaris, Elisabeth Paramythiotou, Nikolaos Koliakos, Nikolaos Markou, Paschalis Paranos, Joseph Meletiadis, Stijn Blot |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Journal of Intensive Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667100X23000531 |
Similar Items
-
In Vitro Antifungal Activity of Three Synthetic Peptides against <i>Candida auris</i> and Other <i>Candida</i> Species of Medical Importance
by: Richar Torres, et al.
Published: (2023-07-01) -
CANDIDA AURIS – EMERGING FUNGAL PATHOGEN
by: Dominika Grondalska, et al.
Published: (2017-04-01) -
Candida haemulonii Complex and Candida auris: Biology, Virulence Factors, Immune Response, and Multidrug Resistance
by: Gómez-Gaviria M, et al.
Published: (2023-03-01) -
Experimental Mouse Models of Disseminated <named-content content-type="genus-species">Candida auris</named-content> Infection
by: Hong Xin, et al.
Published: (2019-10-01) -
Candida auris: Microbiological Characteristics and Laboratory Diagnosis of the Hidden Pathogen
by: Esra YILDIRIM SERVİ, et al.
Published: (2022-08-01)